Skip to content

Into the wild frontier: Mapping the terrain of adverse events in psychedelic-assisted therapies.

Otto Simonsson, Simon B Goldberg, Peter S Hendricks

J Psychopharmacol October 29, 2024 DOI: 10.1177/02698811241292944 via PubMed Central

Summary

AI-generated from the abstract

Psychedelic-assisted therapies are gaining attention as potential treatments for mental health conditions, but their safety profile remains incompletely understood. This article maps the landscape of adverse events that can occur during such therapies, including psychological distress, physiological reactions, and challenging experiences. The authors argue that a systematic framework is needed to categorize and manage these events, drawing on clinical reports and existing literature. They emphasize that while serious adverse events appear rare, mild to moderate reactions are common and require careful protocol design and therapist training. The piece calls for standardized reporting to improve safety monitoring and clinical outcomes in this emerging field.

Study at a glance

Characteristics Review Peer reviewed
Topics Psychedelic-assisted therapy
Keywords Mental health treatment Adverse effects Clinical safety Therapeutic protocols
Citations 4
Key finding Adverse events in psychedelic-assisted therapies range from mild psychological distress to rare serious reactions, and a systematic framework is needed to categorize and manage them.

Abstract

Into the wild frontier: Mapping the terrain of adverse events in psychedelic-assisted therapies.

Explore topics

Comments

No comments yet.

Log in to comment